☆ 4.6 Article

G2/M-Phase-Inhibitory Mitochondrial-Depolarizing Re(I)/Ru(II)/Ir(III)-2,2?-Bipyrimidine-Based Heterobimetallic Luminescent Complexes: An Assessment of In Vitro Antiproliferative Activity and Bioimaging for Targeted Therapy toward Human TNBC Cells

ACS OMEGA (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Chemistry, Multidisciplinary

Ferroptosis-Enhanced Cancer Immunity by a Ferrocene-Appended Iridium(III) Diphosphine Complex

Wen-Jin Wang et al.

Summary: This study reports on an Ir-III complex that can induce ferroptosis, a programmed cell death pathway, under acidic conditions. The complex affects pathways related to cancer immunity and has the potential for effective cancer immunotherapy.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2022)

添加到收藏夹

Article Engineering, Biomedical

Ruthenium complexes boost NK cell immunotherapy via sensitizing triple-negative breast cancer and shaping immuno-microenvironment

Qi Chen et al.

Summary: The study focuses on designing ruthenium (Ru) polypyridyl complexes to enhance NK cells immunotherapy. The RuPOP complex effectively regulates immune suppressors and target proteins in tumor cells, increasing their sensitivity to NK cells. The combination treatment induces ROS generation, activates apoptosis-related receptors, and enhances interactions between NK and tumor cells, leading to caspase 3-dependent apoptosis. Additionally, the treatment boosts NK cell infiltration and reduces MDSC's protumoral capability. This study provides insights for enhancing NK cells immunotherapy and developing more effective clinical treatment options.

BIOMATERIALS (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Anticancer and Antibiotic Rhenium Tri- and Dicarbonyl Complexes: Current Research and Future Perspectives

Kevin Schindler et al.

Summary: Organometallic compounds of rhenium, particularly its tri- and dicarbonyl complexes, have shown promising potential as anticancer and antibiotic drugs due to their ease of preparation, stability, and unique photophysical and luminescent properties. This review focuses on discussing the structural variations and in vitro efficacy of these complexes in the past seven years, with an initial emphasis on tricarbonyl complexes and a later discussion on the future prospects of dicarbonyl species in this field.

MOLECULES (2022)

添加到收藏夹

Article Oncology

Immunotherapy for early triple negative breast cancer: research agenda for the next decade

Paolo Tarantino et al.

Summary: Advancements in the treatment of localized triple negative breast cancer (TNBC) are reshaping the landscape of this disease, with the addition of pembrolizumab showing significant improvement in survival. However, there are still questions regarding patient selection, integration with other treatments, and minimizing side effects.

NPJ BREAST CANCER (2022)

添加到收藏夹

Article Oncology

Clinical Significance of Breast Cancer Molecular Subtypes and Ki67 Expression as a Predictive Value for Pathological Complete Response following Neoadjuvant Chemotherapy: Experience from a Tertiary Care Center in Lebanon

Ali Atoui et al.

Summary: This study aimed to determine the predictive role of breast cancer subtypes in the efficacy and prognosis of neoadjuvant chemotherapy regimens. The results showed significant differences in the response rate to neoadjuvant chemotherapy between different subtypes, and there were significant correlations between pathological complete response and factors such as ER status, HER2, molecular subtypes, and staging.

INTERNATIONAL JOURNAL OF BREAST CANCER (2022)

添加到收藏夹

Review Oncology

Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies

Minru Liao et al.

Summary: This review summarizes the molecular mechanisms of seven major RCD subroutines related to TNBC and the latest progress of small-molecule compounds targeting these subroutines. The combined strategies of different drugs regulating RCD subroutines have therapeutic potential for TNBC. Several small-molecule compounds have shown promising results in clinical trials for TNBC by targeting RCD subroutines.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)

添加到收藏夹

Review Chemistry, Multidisciplinary

Metal Complexes in Target-Specific Anticancer Therapy: Recent Trends and Challenges

Gemechu Shumi et al.

Summary: Biomolecule-conjugated metal complexes have shown tremendous advantages in cancer therapy. This review discusses chemoselective biomolecules-bound metal complexes as prospective cancer therapy-targeted agents, and addresses current clinical issues and recent therapeutic strategies in targeted cancer therapy, providing insights for the future direction of metal complexes-based targeted cancer therapy.

JOURNAL OF CHEMISTRY (2022)

添加到收藏夹

Review Chemistry, Multidisciplinary

Exploring the Potential of Metallodrugs as Chemotherapeutics for Triple Negative Breast Cancer

Nazia Nayeem et al.

Summary: This review focuses on the potential of coordination and organometallic compounds as chemotherapeutics for triple negative breast cancer (TNBC), which has poor prognoses and survival rates compared to other types of breast cancer. The review lists references for metal-based compounds studied in TNBC cell lines and in vivo, and aims to highlight the most promising metal-based compounds with potential as chemotherapeutic agents for TNBC.

CHEMISTRY-A EUROPEAN JOURNAL (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Novel Pyrimidine Derivatives as Potential Anticancer Agents: Synthesis, Biological Evaluation and Molecular Docking Study

Beata Tylinska et al.

Summary: New pyrimidine derivatives were designed, synthesized, and analyzed for their anticancer properties in this study. The compounds exhibited inhibitory activity on various cancer cell lines, with stronger impact on P-glycoprotein activity in doxorubicin-resistant cell cultures. These compounds showed more lipophilic character than doxorubicin, determining their affinity for molecular targets and passive transport through biological membranes. Additionally, their potential as inhibitors of topoisomerase II and DNA intercalation was investigated through molecular docking.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Article Chemistry, Inorganic & Nuclear

2,2′-Bipyrimidine-based luminescent Ru(ii)/Ir(iii)-arene monometallic and homo- and hetero-bimetallic complexes for therapy against MDA-MB-468 and caco-2 cells

Nilmadhab Roy et al.

Summary: By synthesizing 2,2'-bipyrimidine-based complexes, LRuIr was found to exhibit inhibitory effects on both MDA-MB-468 and Caco-2 cells, with apoptotic events occurring in MDA-MB-468 cancer cells through cell cycle arrest.

DALTON TRANSACTIONS (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

Pyrimidine: a review on anticancer activity with key emphasis on SAR

Aastha Mahapatra et al.

Summary: Cancer is a global health challenge with resistance to existing drugs, prompting research on novel anticancer agents such as pyrimidine derivatives. This review focuses on the structure-activity relationship of pyrimidine derivatives as anticancer agents in the past decade, aiming to assist in the development of more potent and efficacious drugs.

FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Cisplatin prevents breast cancer metastasis through blocking early EMT and retards cancer growth together with paclitaxel

Haitao Wang et al.

Summary: Cisplatin at different doses has varying effects on breast cancer growth and metastasis, with higher doses inhibiting both growth and metastasis but causing severe side effects, and lower doses only blocking metastasis. Cisplatin prevents breast cancer metastasis by blocking early EMT steps.

THERANOSTICS (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Rationally Designed Ruthenium Complexes for Breast Cancer Therapy

Golara Golbaghi et al.

MOLECULES (2020)

添加到收藏夹

Review Environmental Sciences

Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies

Mauricio A. Medina et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)

添加到收藏夹

Review Oncology

Optimal Systemic Treatment for Early Triple-Negative Breast Cancer

Jenny Furlanetto et al.

BREAST CARE (2020)

添加到收藏夹

Article Chemistry, Inorganic & Nuclear

Organoruthenium(II) Complexes Bearing an Aromatase Inhibitor: Synthesis, Characterization, in Vitro Biological Activity and in Vivo Toxicity in Zebrafish Embryos

Golara Golbaghi et al.

ORGANOMETALLICS (2019)

添加到收藏夹

Article Chemistry, Medicinal

In Vivo Anticancer Activity of a Rhenium(I) Tricarbonyl Complex

Chilaluck C. Konkankit et al.

ACS MEDICINAL CHEMISTRY LETTERS (2019)

添加到收藏夹

Article Oncology

Potent In Vitro and In Vivo Anticancer Activity of New Bipyridine and Bipyrimidine Gold (III) Dithiocarbamate Derivatives

Muhammad Altaf et al.

CANCERS (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

Iridium(III) Complexes Targeting Apoptotic Cell Death in Cancer Cells

Dik-Lung Ma et al.

MOLECULES (2019)

添加到收藏夹

Review Chemistry, Inorganic & Nuclear

Organometallic and coordination rhenium compounds and their potential in cancer therapy

Elisabeth B. Bauer et al.

COORDINATION CHEMISTRY REVIEWS (2019)

添加到收藏夹

Review Chemistry, Multidisciplinary

Therapeutic potential of heterocyclic pyrimidine scaffolds

Sanjiv Kumar et al.

CHEMISTRY CENTRAL JOURNAL (2018)

添加到收藏夹

Review Crystallography

Non-Platinum Metal Complexes as Potential Anti-Triple Negative Breast Cancer Agents

Eva Maria Dominguez-Martis et al.

CRYSTALS (2018)

添加到收藏夹

Article Chemistry, Multidisciplinary

In Vitro Anticancer Activity and in Vivo Biodistribution of Rhenium(I) Tricarbonyl Aqua Complexes

Kevin M. Knopf et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells

Cecilia P. Popolin et al.

PLOS ONE (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

Synthesis, Characterization, and Biological Studies of a Piperidinyl Appended Dipicolylamine Ligand and Its Rhenium Tricarbonyl Complex as Potential Therapeutic Agents for Human Breast Cancer

Amali Subasinghe et al.

BIOINORGANIC CHEMISTRY AND APPLICATIONS (2016)

添加到收藏夹

Article Medicine, Research & Experimental

Inhibition of cancer cell growth by ruthenium complexes

Joji Iida et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2016)

添加到收藏夹

Review Medicine, General & Internal

Breast Cancer Screening for Women at Average Risk 2015 Guideline Update From the American Cancer Society

Kevin C. Oeffinger et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)

添加到收藏夹

Article Chemistry, Inorganic & Nuclear

Impact of the Halogen Substitution Pattern on the Biological Activity of Organoruthenium 8-Hydroxyquinoline Anticancer Agents

Mario Kubanik et al.

ORGANOMETALLICS (2015)

添加到收藏夹

Article Biochemistry & Molecular Biology

Organometallic Iridium(III) Anticancer Complexes with New Mechanisms of Action: NCI-60 Screening, Mitochondrial Targeting, and Apoptosis

Jessica M. Hearn et al.

ACS CHEMICAL BIOLOGY (2013)

添加到收藏夹

Article Chemistry, Multidisciplinary

Diffusion of organic dyes in bovine serum albumin solution studied by fluorescence correlation spectroscopy

Satyajit Patra et al.

RSC ADVANCES (2012)

添加到收藏夹

Article Chemistry, Multidisciplinary

AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility

Garrett M. Morris et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.